Dr. Jeffrey W. Sherman, MD, FACP?
Update this Profile
Dr. Jeffrey W. Sherman, MD, FACP, Infectious Disease Specialist
Verified Doctor
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Jeffrey W. Sherman, MD, FACP

Infectious Disease Specialist | Infectious Disease

520 Lake Cook Rd # 250 Deerfield IL, 60015

About

Dr. Jeffrey W. Sherman, a seasoned expert in clinical research and pharmaceutical development, is the Chief Medical Officer Emeritus at Horizon Therapeutics, now part of Amgen's rare disease division. With over 35 years of experience, Dr. Sherman has held leadership roles in several top pharmaceutical companies, contributing to advancements in rare disease treatments. Throughout his career, Dr. Sherman has played pivotal roles in clinical, regulatory, and development strategies, notably shaping the approval of groundbreaking therapies. He has served on advisory boards and committees, including the Drug Information Association (DIA) and the FDA’s Clinical Trial Transformation Initiative (CTTI). A passionate advocate for rare disease research, Dr. Sherman continues to influence the field through his work with organizations like Global Genes and the National Organization for Rare Diseases. His commitment to improving patient care and advancing innovative therapies remains a hallmark of his distinguished career.

Education and Training

Lake Forest College bachelor's degree in biology 0

Chicago Medical School at Rosalind Franklin University of Medicine & Science MD 1981

Board Certification

Infectious Disease (Internal Medicine)

American Board of Internal Medicine (ABIM)

Provider Details

Male English

Areas of expertise and specialization

Clinical Research

Faculty Titles & Positions

  • Chief Medical Officer Emeritus at Horizon Therapeutics now Amgen (Rare Disease) -
  • Chief Resident Northwestern University -
  • FDA Clinical Trial Transformation Initiative (CTTI) Steering Committee Board of Advisors of the Center for Information and Study on Clinical Research Participation (CISCRP -
  • Board of Directors Strongbridge Biopharma and Xeris Pharmaceuticals -
  • Adjunct Assistant Professor of Medicine Northwestern University Feinberg School of Medicine -
  • Board Member Rosalind Franklin University of Medicine and Science College of Pharmacy Advisory Board -
  • Board of Advisors Center for Information and Study on Clinical Research Participation (CISCRP) -
  • Scientific Advisory Board Cures Within Reach -
  • Board Member Erie Family Health Foundation -

Awards

  • PharmaVoice 100 2020 PharmaVoice 

Professional Memberships

  • Drug Information Association (DIA) Inagural Fellow  
  • American College of Physicians (FACP)  
  • National Board of Medical Examiners  
  • Global Genes Medical and Scientific Advisory Board  
  • European Organization for Rare Diseases (EURORDIS)  
  • National Organization for Rare Diseases (NORD)  

Fellowships

  • University of California-San Francisco (UCSF) infectious diseases 

Charities and Philanthropic Endeavors

  • Center for Healthcare Innovation (CHI)
  • Cures Within Reach
  • Erie Family Health Foundation
  • The Center for Information and Study on Clinical Research Participation (CISCRP)
  • National Organization for Rare Diseases (NORD) and the European Organization for Rare Diseases (EURORDIS)

Internships

  • internal medicine at Northwestern University

Fellowships

  • University of California - San Francisco

Professional Society Memberships

  • Fellow of the VI -, Drug Information Association, Center for Healthcare Innovation, Drug Information Association, American College of Physicians, National Board of Medical Examiners, Global Genes Medical and Scientific Advisory Board, European Organization for Rare Diseases, National Organization for Rare Diseases

Articles and Publications

  • on drug development

What do you attribute your success to?

  • Focusing on his patients as people To enhance well being for all of us

Philanthropic Initiatives

  • Center for Healthcare Innovation (CHI)Cures Within ReachErie Family Health FoundationThe Center for Information and Study on Clinical Research Participation (CISCRP)National Organization for Rare Diseases (NORD) and the European Organization for Rare Diseases (EURORDIS)

Teaching and speaking

  • Stanford MTRAM

Areas of research

Rare Diseases

Dr. Jeffrey W. Sherman, MD, FACP's Practice location

Private Consultant - Amgen Deerfield

520 Lake Cook Rd # 250 -
Deerfield, IL 60015
Get Direction
New patients: 847-236-0921
https://www.linkedin.com/in/jeff-sherman-md-facp-16a6745/

Amgen Deerfield

1 Horizon Way -
Deerield, Illinois 60015
Get Direction
New patients: 847-383-3011

Dr. Jeffrey W. Sherman, MD, FACP's reviews

(0)
Write Review

Media Releases

Get to know Clinical Research Specialist Dr. Jeffrey W. Sherman.

An experienced clinical research and pharmaceutical development specialist, Dr. Sherman was the Chief Medical Officer now Emeritus at Horizon Therapeutics now Amgen (Rare Disease) located in Deerfield, Illinois. 

Educated in the United States, he earned his bachelor’s degree in biology from Lake Forest College before embarking on his medical voyage at the Rosalind Franklin University of Medicine and Science/The Chicago Medical School, where he obtained his medical degree. 

Following this, Dr. Sherman undertook rigorous training, completing an internship and residency in internal medicine at Northwestern University, where his exceptional skills led him to serve as Chief Resident. Further enhancing his expertise, he pursued fellowship training in infectious diseases at the University of California-San Francisco (UCSF), as well as contributing to research endeavors as a research associate at the Howard Hughes Medical Institute at UCSF, specializing in allergy and immunology.

Recognized as a Fellow of the American College of Physicians (FACP), the doctor is board-certified in internal medicine and infectious diseases by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

With over 35 years of invaluable experience in the field, he has left an indelible mark on the industry landscape, having traversed through various prominent roles in renowned pharmaceutical companies such as IDM Pharma, Takeda Global Research and Development, NeoPharm, Searle/Pharmacia, and Squibb/Bristol-Myers Squibb. His influence spans across various advisory boards and committees, exemplified by his past board of directors chair of the Drug Information Association (DIA) and membership on the Board of Directors. Noteworthy is his pivotal role in steering the DIA Annual Meeting as chairperson and his recognition with an Outstanding Service Award, further solidifying his reputation as an exemplary leader in the field. 

Having served as a liaison to the FDA Clinical Trial Transformation Initiative (CTTI) Steering Committee and on the Board of Advisors of the Center for Information and Study on Clinical Research Participation (CISCRP), Dr. Sherman has actively contributedHa to shaping policy and advancing clinical research methodologies.

Furthermore, his philanthropic endeavors underscore his commitment to addressing rare diseases, evident through his involvement with the Global Genes Medical and Scientific Advisory Board and his engagement with the National Organization for Rare Diseases (NORD) and the European Organization for Rare Diseases (EURORDIS).

Recommended Articles

  • Langerhans cells

    These are dendritic skin cells and contain Birbeck granules which is an organelle. In almost all the layers of the epidermis, langerhans cells are found. In the stratum spinosum they are the most prominent. Also, in the papillary dermis they occur. They are also found in the mucosa of the vaginal...

  • Is There a Vaccine Against Lyme Disease?

    Spring brings a well-heightened mood to play outdoors, but it also marks the unpleasant beginning of Lyme disease season after season. The disease is rarely chronic. If there is a delay in the treatment, it might cause arthritis, meningitis, and heart problems. The patients can recover completely...

  • What Is the Epiglottis?

    What is Epiglottis?Epiglottis is a elastic flap of tissue that is shaped like a thin leaf and situated at the root of the tongue. It protects the opening between the vocal cords, known as the entrance of the glottis. Epiglottis is covered with mucous membrane, which is a yellow elastic cartilage...

  • Promising COVID-19 Treatments

    In America alone, we have 645,621 confirmed cases of coronavirus and 52,736 of them have recovered. More and more countries are also reporting improvements when it comes to their statistics. We are slowly flattening the curve. The attempts to address this pandemic are working. The effects of...

  • Can You Contract Cholera Through Other Means Besides Water?

    Can You Contract Cholera Through Other Means Besides Water?Cholera is an infection that causes thousands of deaths around the world every year. The biggest challenge posed by cholera is that it is difficult to control and treat at the same time. The infection spreads very fast affecting a huge...

  • Myths About Meningitis

    You've probably heard stories of people who have died of meningitis, or you've heard that contracting it is as simple as kissing someone with the infection. However, being aware of what is fact and what is fiction is important. Below are some of the myths about meningitis and their truths. ...